Researchers have developed an artificial intelligence model that could help identify people at increased risk of pancreatic cancer up to five years before diagnosis, potentially helping earlier detection.
Discover the many professionals working behind every clinical trial and their roles. Learn about the people you will meet if you take part and the work that goes on behind the scenes.
Following years of campaigning, patients in England with a specific type of incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
Through the TAME study, researchers are investigating whether metformin, a common diabetes drug, could help delay age-related diseases and extend the number of years people live in good health.
Clinical trial participants are protected by strict ethical and regulatory safeguards before and throughout a study. Learn how informed consent, ongoing safety monitoring and the right to withdraw help protect participants’ rights.
A personalised cancer vaccine has shown promising results in a Phase 3 clinical trial, helping to prevent melanoma from returning in patients at high risk of their cancer coming back.
Solomon was diagnosed with Multiple Myeloma in 2018. Whilst undergoing many different treatments, he began to study his health which, led him to question how his experience could help shape future research.
Over 1,800 British Research Panel members signed up to the T1DRA study, a type 1 diabetes study led by the University of Bristol. The study aims to find how many adults in the UK are at increased risk of developing type 1 diabetes.
Clinical studies often seek participants with specific conditions, treatment histories and health characteristics. Learn why you may not be able to take part, even when the study concerns your condition.
An experimental treatment for chronic hepatitis B has shown encouraging results in two large phase 3 clinical trials. The studies involved more than 1,800 adults across 29 countries with around one in five participants achieving a functional cure.
Gilbert was diagnosed with hypertrophic cardiomyopathy in 1990. After receiving a heart transplant in 2016, he acknowledges how patient voices have raised awareness of the condition so that treatments and services can progress.
A new analysis of NHS data has found a concerning rise in type 2 diabetes among young adults in England. 12,000 people under 30 are now living with type 2 diabetes.
Learn how the Medicines and Healthcare products Regulatory Agency, (MHRA) evaluates medicines, monitors safety, and oversees clinical research in the UK.
New Ebola vaccine has entered its first human clinical trial. Researchers hope the study will demonstrate the vaccine is safe and capable of generating an immune response.
Discover how the TWINS study for Multiple Sclerosis, decoded by Prof. Collongues, explores treatment discontinuation to improve the quality of life and safety of stable patients.
Through signing up as a member, we will keep you up to date with the latest research news, member stories and community updates through our monthly newsletters. You can also follow us on Facebook, Twitter and Instagram.
We always value hearing from our members. We send out surveys and questionnaires and conduct interviews so that you can share your input on a range of topics. If there is something in particular you wish to share, feel free to email us on info@britishresearchpanel.co.uk.
As a member, we will email you with surveys and questionnaires so that you have the opportunity to share your input on a range of topics.
This page is updated ahead of our newsletters. You can also stay up to date with us on Facebook, Twitter and Instagram.
Yes, we encourage you to share these resources and help raise awareness of clinical research and our member stories.
